Vaxxinity【VAXX】銘柄情報 | ADVFN

US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Vaxxinity Inc (VAXX) 銘柄情報

Vaxxinity Inc (VAXX)

0.1111

0.00

( 0.00% )

更新日時： 09:00:00

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.1111

買値

0.1068

売値

0.107

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

0.1111

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

-

発行済株式数

126,747,684

配当利回り

-

PER

-0.24

1 株当たり利益 (EPS)

-0.45

歳入

-

純利益

-56.93M

Vaxxinity Inc is engaged in the development and commercialization of prophylactic and therapeutic vaccines to combat chronic disorders and infectious diseases with large patient populations and unmet medical needs. Its pipeline primarily consists of five programs focused on chronic disease, particul... Vaxxinity Inc is engaged in the development and commercialization of prophylactic and therapeutic vaccines to combat chronic disorders and infectious diseases with large patient populations and unmet medical needs. Its pipeline primarily consists of five programs focused on chronic disease, particularly neurodegenerative disorders, in addition to other neurology and cardiovascular indications. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

vaxxinity.com

本社

Wilmington, Delaware, USA

設立

-

Vaxxinity UB-312 Parkinson’s Trial Results Published in Nature Medicine

UB-312 is the first Parkinson's candidate to reduce pathology as measured by a seed amplification assay, and suggest clinical improvement on motor experiences of daily living. Data demonstrates...

Form 15-12G - Securities registration termination [Section 12(g)]

Form DEF 14C - Other definitive information statements

Vaxxinity Issues Shareholder Letter

CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (“Vaxxinity”, “we”, “us” or the “Company”) (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of...

Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock

CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (“Vaxxinity”, “we”, “us” or the “Company”) (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of...

Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting

CAPE CANAVERAL, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines, today announced it will present...

Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates

CAPE CANAVERAL, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported...

Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024

LISBON, Portugal, March 07, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (NASDAQ: VAXX), a U.S. company pioneering the development of a new class of medicines, announced positive clinical data from...

Form 8-K - Current report

Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published

Preclinical data published in the Journal of Lipid Research indicate VXX-401 is well-tolerated, with no safety signals observed, and robustly reduces LDL-C in cynomolgus monkeys. A Phase 1 trial...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

VAXX - Frequently Asked Questions (FAQ)

What is the current Vaxxinity share price?

The current share price of Vaxxinity is US$ 0.1111

How many Vaxxinity shares are in issue?

Vaxxinity has 126,747,684 shares in issue

What is the market cap of Vaxxinity?

The market capitalisation of Vaxxinity is USD 14.08M

What is the 1 year trading range for Vaxxinity share price?

Vaxxinity has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Vaxxinity?

The price to earnings ratio of Vaxxinity is -0.24

What is the reporting currency for Vaxxinity?

Vaxxinity reports financial results in USD

What is the latest annual profit for Vaxxinity?

The latest annual profit of Vaxxinity is USD -56.93M

What is the registered address of Vaxxinity?

The registered address for Vaxxinity is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Vaxxinity website address?

The website address for Vaxxinity is vaxxinity.com

Which industry sector does Vaxxinity operate in?

Vaxxinity operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
PHIOPhio Pharmaceuticals Corporation	US$ 7.929 (369.17%)	267.98M
SLRXSalarius Pharmaceuticals Inc	US$ 4.0684 (159.96%)	114.09M
ATPCAgape ATP Corporation	US$ 2.10 (66.67%)	82.47M
VRMEVerifyMe Inc	US$ 4.0214 (57.70%)	53.89M
XXII22nd Century Group Inc	US$ 6.7167 (37.36%)	22.65M
EHGOEshallgo Inc	US$ 1.28 (-60.86%)	5.65M
CMTLComtech Telecommunications Corporation	US$ 2.386 (-42.23%)	3.9M
HUBCWHub Cyber Security Ltd	US$ 0.0176 (-41.33%)	265.23k
SVMHSRIVARU Holding Ltd	US$ 0.0363 (-41.26%)	164.15M
LAESSEALSQ Corporation	US$ 3.375 (-41.10%)	70.01M
GCTKGlucoTrack Inc	US$ 0.1386 (18.46%)	647.18M
PHIOPhio Pharmaceuticals Corporation	US$ 7.929 (369.17%)	267.98M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.0625 (-29.06%)	181.72M
SVMHSRIVARU Holding Ltd	US$ 0.0363 (-41.26%)	164.15M
NVDANVIDIA Corporation	US$ 132.335 (-2.63%)	162.52M

PonkenPlonken

PonkenPlonken 7月前

i feel sorry for Mei Mei and the team. The timing of the IPO and the small cap biotech bearmarket hurt them badly. Wrong place wrong time.
Lets see, i dont think you can hold Mei Mei down.

TrendTrade2016

TrendTrade2016 7月前

VAXX monster move

TrendTrade2016

TrendTrade2016 7月前

TrendTrade2016

TrendTrade2016 7月前

VAXX blowing up

glenn1919

glenn1919 8月前

VAXX................................https://stockcharts.com/h-sc/ui?s=VAXX&p=W&b=5&g=0&id=p86431144783

Renee

VAXX delisted from the Nasdaq to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions

stock1ace1

stock1ace1 8月前

Why? Delisting ..

Triple nickle

Triple nickle 9月前

Awl416

Awl416

Tom turtles

Tom turtles 9月前

Lol...bye bye VAXX...good riddance

Awl416

Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock

Awl416

Awl416 10月前

Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024

81vette

81vette 10月前

not off hand,look on fda site,let us know,thanks!!!

Monroe1

Monroe1 10月前

Any idea when the Phase 3 trial should finish?

Monksdream

Monksdream 12月前

VAXX new 52 week low

Monksdream

Monksdream 1年前

Monksdream

Monksdream 1年前

VAXX new 52 week low

Monksdream

Monksdream 1年前

VAXX new 52 week low

Monksdream

Monksdream 1年前

81vette

81vette 2年前

new and effective covid booster news coming is the thought,15 days of charting up and institutions loading while crickets are chirping

81vette

81vette 2年前

https://ih.advfn.com/stock-market/NASDAQ/vaxxinity-VAXX/stock-news/89692734/vaxxinity-announces-positive-topline-pivotal-phase

81vette

81vette 2年前

10Xs ave vol,blowing up scanners on this low float

81vette

81vette 2年前

1M short ,squeeze babe !!! could be big news enroute with institutional buying like this

81vette

81vette 2年前

biggest ever institution loading> Bank Of America 3.22 mm +3.20 mm +20179.3%
Vanguard 1.53 mm +1.48 mm +2676.7%
Marshall Wace 620.46 k +620.46 k NEW
Element Capital Management 376.89 k +376.89 k NEW
Creative Planning 277.52 k +277.52 k NEW
Renaissance Technologies 262.40 k +262.40 k NEW
Millennium Management 213.62 k +213.62 k NEW
Prime Movers Lab 17.85 mm -179.00 k -1.0%
Two Sigma Investments 128.52 k +128.52 k NEW
Ghisallo Capital Management 100.00 k +100.00 k NEW

81vette

81vette 2年前

3Xs ave vol.,no news,dbl bottom,47% insider owned

bandit007

bandit007 3年前

Loaded the crap out of this today

bandit007

bandit007 3年前

Sexy looking bottom chart. Starting to move up now. $VAXX

bandit007

bandit007 3年前

Stop losses below 3 got taken out. Should start moving up now

bandit007

bandit007 3年前

Took a few down here

TheFinalCD

TheFinalCD 3年前

and on low volume

bandit007

bandit007 3年前

bandit007

bandit007 3年前

bandit007

bandit007 3年前

bandit007

bandit007 3年前

I only hold a small position speculating here. Could be either gold or fool’s gold. Could pay off well if it ends up being the real deal. GL

Deano361

Deano361 3年前

Trading nicely today now and not spikey

Deano361

Deano361 3年前

I'm in this one now. Can't figure out if real or not. Some guy on Twits board claims it's a Nancy Pelosi fraud lol! I have no idea but if they truly figure out a Alz vaccine this will be like Moderna in the 100s

bandit007

bandit007 3年前

Nice bounce back from the morning dip. $VAXX

bandit007

bandit007 3年前

VAXX hod close?

crudeoil24

crudeoil24 3年前

Nice trade! Maybe some news coming next week.

TheFinalCD

TheFinalCD 3年前

5.74 vol HALT down

only P1 news

I learned from crude to be careful with P1's I got burned on one that I lost $80,000

#HardLesson

Awl416

TheFinalCD

TheFinalCD 3年前

crudeoil24

crudeoil24 3年前

VAXX halted > Nasdaq circuit breaker.

crudeoil24

crudeoil24 3年前

Vaxxinity Shares Surge More Than 40% in Trading Debut After IPO VAXX
12:02 pm ET November 11, 2021 (Dow Jones)

crudeoil24

crudeoil24 3年前

Vaxxinity, Inc. is a biotechnology company. The Company’s synthetic peptide vaccine platform (Vaxxine Platform) enables a new class of therapeutics that will improve the access to treatments for a range of indications. Its Vaxxine Platform is designed to connect the immune system to convert the body into its own drug factory, stimulating the production of antibodies with a therapeutic or protective effect. Its technology uses synthetic peptides to mimic and optimally combine biological epitopes in order to selectively activate the immune system, producing antibodies against only the desired targets, including self-antigens, making possible the safe and effective treatment of chronic diseases by vaccines. The modular and synthetic nature of its Vaxxine Platform provides significant in candidate development and has generated multiple product candidates that it is designing for many chronic diseases.

Sefton Resources

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約